Reckitt Benckiser Healthcare (UK) Limited
Quick facts
Marketed products
- Ibuprofen Acid · Pain Management, Inflammation
Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce the production of prostaglandins, thereby decreasing inflammation, pain, and fever.
Phase 3 pipeline
- Placebo of IR tablet
A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. - Placebo of PR tablet
A placebo tablet contains no active pharmaceutical ingredient and produces no direct pharmacological effect.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Reckitt Benckiser Healthcare (UK) Limited portfolio CI brief
- Reckitt Benckiser Healthcare (UK) Limited pipeline updates RSS
Frequently asked questions about Reckitt Benckiser Healthcare (UK) Limited
What are Reckitt Benckiser Healthcare (UK) Limited's marketed drugs?
Top marketed products include Ibuprofen Acid.
What is Reckitt Benckiser Healthcare (UK) Limited's pipeline?
Reckitt Benckiser Healthcare (UK) Limited has 2 drugs in Phase 3, 0 in Phase 2, 4 in Phase 1. Late-stage candidates include Placebo of IR tablet, Placebo of PR tablet.
Related
- Ibuprofen Acid · Pain Management, Inflammation
- Sector hub: All tracked pharma companies